Mark Talamonti to Lipoxygenase Inhibitors
This is a "connection" page, showing publications Mark Talamonti has written about Lipoxygenase Inhibitors.
Connection Strength
0.096
-
Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res. 2008 Oct 15; 14(20):6525-30.
Score: 0.080
-
5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions. Cancer Res. 2005 Jul 15; 65(14):6011-6.
Score: 0.016